John Lewis and Microsoft Create Interactive Element to Christmas Campaign

Author:
Publish date:

British department store John Lewis has brought an interactive element to its hit Christmas ad, "#MontythePenguin."

"Monty's Magical Toy Machine" is an in-store interactive installment that uses Microsoft Kinect to allow kids to bring their toys to life, much like Monty in the commercial (found below). By scanning in the toy, a moving, dancing 3D image of it will appear on a screen.

Says Craig Inglis, director of marketing at John Lewis, "Each year we look for new ways to amplify our Christmas campaign, and creating Monty’s Magical Toy Machine with Microsoft is one of our most exciting ideas yet. I hope this unique experience will bring the magic of Christmas to life for our Oxford Street customers, both young and old alike.”

Read the full story here on The Drum.

Related

ZYLIA-Mobile-PR

Zylia Takes Portable 360-Degree Recording to New Territory With Tablet-Based Control of Its Acclaimed ZM-1 Microphone

Making high-resolution 360-degree recording in the field easier than ever, Zylia today introduced a Windows tablet-compatible version of ZYLIA software for the company's acclaimed ZYLIA ZM-1 microphone. Convenient tablet-based control over the ZM-1, a compact 3rd order Ambisonics microphone, gives sound engineers and musicians a lightweight and highly portable solution for capturing immersive audio in any environment.

Veritone_NAB-Product-of-the-Year

Veritone Announces NAB Show Product of the Year Award Win for Veritone Attribute

Veritone, Inc. (Nasdaq: VERI), the creator of the world's first operating system for artificial intelligence, aiWARE™, today announced that its Veritone Attribute application, a near real-time media attribution solution, received a Product of the Year Award in the Best New Radio Technology category at the recent 2019 NAB Show in Las Vegas. The first official awards at the NAB Show, the program recognizes the most significant and promising new products and technologies showcased by exhibitors.